Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes.
- DOI
- 10.3390/medsci13030141
- Published
- 2025 Aug 18
- Container
- Medical sciences (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/medsci13030141,
title = {Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes.},
author = {Pinheiro MM and Pinheiro FMM and Di Serio BF and Padilla N and Nwosu BU and Della-Morte D and Ricordi C and Infante M},
year = {2025},
journal = {Medical sciences (Basel, Switzerland)},
doi = {10.3390/medsci13030141},
url = {https://doi.org/10.3390/medsci13030141}
}RIS
TY - JOUR TI - Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes. AU - Pinheiro MM AU - Pinheiro FMM AU - Di Serio BF AU - Padilla N AU - Nwosu BU AU - Della-Morte D AU - Ricordi C AU - Infante M PY - 2025 JO - Medical sciences (Basel, Switzerland) DO - 10.3390/medsci13030141 UR - https://doi.org/10.3390/medsci13030141 ER -
APA
MM, P., FMM, P., BF, D. S., N, P., BU, N., D, D., C, R., & M, I. (2025). Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes.. Medical sciences (Basel, Switzerland). https://doi.org/10.3390/medsci13030141
Source records
- pubmed · retrieved 2026-09-27T14:37:33.357Z
- europe-pmc · retrieved 2026-09-27T14:37:33.380Z